Kiora Pharmaceuticals (KPRX) Exchange Rate Effect (2014 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Exchange Rate Effect came in at $20103.0 in Q1 2026, up 98.2% YoY from $10143.0 in Q1 2025, and up 7.19% on a QoQ basis from $18755.0 in Q4 2025.
Kiora Pharmaceuticals (KPRX) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 13 years of Exchange Rate Effect data on file, last reported at $20103.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 98.2% year-over-year to $20103.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183594.0 (up 4564.48% YoY) and the FY2025 annual result came in at $173634.0, up 403.39% from the prior year.
- Exchange Rate Effect rose to $20103.0 in Q1 2026, from $18755.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $131582.0 in Q2 2025 to a low of -$136205.0 in Q2 2022.
- A 5-year average of $5146.4 and a median of $10143.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 424.71% — and 2025, when it surged 1785.4%.
- Tracing KPRX's Exchange Rate Effect over 5 years: stood at $48961.0 in 2022, then jumped by 149.55% to $122184.0 in 2023, then sank by 161.78% to -$75485.0 in 2024, then soared by 124.85% to $18755.0 in 2025, then gained by 7.19% to $20103.0 in 2026.
- The last three Exchange Rate Effect figures came in at $20103.0 (Q1 2026), $18755.0 (Q4 2025), and $13154.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - | -16,567.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16,567.00 |
| Jun 30, 2026 | -16,567.00 |
| Mar 31, 2026 | 20,103.00 |
| Mar 31, 2026 | 20,103.00 |
| Dec 31, 2025 | 18,755.00 |
| Dec 31, 2025 | 18,755.00 |
| Sep 30, 2025 | 13,154.00 |
| Sep 30, 2025 | 13,154.00 |
| Jun 30, 2025 | 131,582.00 |
| Jun 30, 2025 | 131,582.00 |
| Mar 31, 2025 | 10,143.00 |
| Mar 31, 2025 | 10,143.00 |
| Dec 31, 2024 | -75,485.00 |
| Dec 31, 2024 | -75,485.00 |
| Sep 30, 2024 | 62,299.00 |
| Sep 30, 2024 | 62,299.00 |
| Jun 30, 2024 | 6,979.00 |
| Jun 30, 2024 | 6,979.00 |
| Mar 31, 2024 | -51,024.00 |
| Mar 31, 2024 | -51,024.00 |